Why the study?
Does Angiotensin II stimulation induce IGF-I and ET-1 formation via ERK signaling differently in failing versus nonfailing human ventricular myocytes?
Does Angiotensin II stimulation induce IGF-I and ET-1 formation via ERK signaling differently in failing versus nonfailing human ventricular myocytes?
The altered growth factor production in failing human ventricular myocytes is associated with a significant derangement in intracellular Angiotensin II-ERK signaling, providing mechanistic support for the use of Angiotensin II antagonism in heart failure.
Answers are grounded in this paper and cite their sources.
Should not change HF therapy; leaves open whether impaired myocyte ERK signaling translates to human disease.
Angiotensin II was reported to induce insulin-like growth factor-I and endothelin-1 gene expression and peptide release by ventricular cardiomyocytes. However, the progression from cardiac hypertrophy to failure in humans is characterized by a reduced myocyte expression of insulin-like growth factor-I and endothelin-1, notwithstanding the enhanced cardiac generation of angiotensin II. In the present study we investigated the functional status of the signaling pathways responsible for angiotensin II-induced endothelin-1 and insulin-like growth factor-I formation in human ventricular myocytes isolated from patients with dilated (n = 19) or ischemic (n = 14) cardiomyopathy and nonfailing donor hearts (n = 6).In human nonfailing ventricular myocytes, angiotensin II (100 nmol/l) induced insulin-like growth factor-I and endothelin-1 gene expression, and peptide release was mediated by extracellular signal-regulated kinase activation and inhibited by extracellular signal-regulated kinase antagonism (PD98059, 30 micromol/l), endothelin-1 formation being partially reduced also by c-Jun N-terminal kinase inhibition (SP600125, 10 micromol/l); insulin-like growth factor-I and endothelin-1 formations were unaffected by the inhibition of p38 mitogen-activated protein kinase (SB203580, 10 micromol/l) and Janus tyrosine kinase 2 (AG490, 10 micromol/l). In failing myocytes, angiotensin II failed to induce insulin-like growth factor-I and endothelin-1 formation; angiotensin II-induced extracellular signal-regulated kinase activation was significantly impaired (-88% vs. controls) although c-Jun NH2-terminal kinase activation was preserved. The impaired extracellular signal-regulated kinase phosphorylation in failing myocytes was associated with increased myocyte levels of mitogen-activated protein kinase phosphatases.Therefore, the altered growth factor production in failing myocytes is associated with a significant derangement in intracellular signaling.
No takes yet. Share an insight, caveat, or question.
Modesti et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: